Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine;Phenomene de Raynaud severe associe a un traitement par interferon beta-1a et fluoxetine

Annales de Medecine Interne

Volumn 151, Issue 5, 2000, Pages 424-425

  De Broucker, Thomas ^a   Lhote, François ^a  

^a DELAFONTAINE HOSPITAL   (France)

Author keywords

Fluoxetine; Interferon beta 1a; Raynaud's phenomenon

Indexed keywords

BETA1 INTERFERON; BETA1A INTERFERON; FLUOXETINE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; BETA INTERFERON; HEPARIN; ILOPROST; IMMUNOLOGICAL ADJUVANT; VASODILATOR AGENT;

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; DISEASE SEVERITY; FEMALE; HUMAN; RAYNAUD PHENOMENON; SYMPTOMATOLOGY; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG COMBINATION; MULTIPLE SCLEROSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTICOAGULANTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HEPARIN; HUMANS; ILOPROST; INTERFERON-BETA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RAYNAUD DISEASE; VASODILATOR AGENTS;

EID: 0033793273     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Interferon beta 1a
2. Newer versus older treatments for relapsing-remitting multiple sclerosis
3. Safety profile of interferon-alpha therapy
4. Digital vasculitis associated with interferon therapy
5. Severe necrotising cutaneous lesions complicating treatment with interferon beta 1-a
6. Serotonin reuptake inhibitor's in Raynaud's phenomenon
7. Fluoxetine-induced Raynaud's phenomenon
8. Severe Raynaud's phenomenon associated with interferon-beta treatment for multiple sclerosis
9. Fluoxetin-induced pulmonary granulomatosis
10. Urticarial vasculitis induced by fluoxetine